Cargando…
Interstitial Flow Recapitulates Gemcitabine Chemoresistance in A 3D Microfluidic Pancreatic Ductal Adenocarcinoma Model by Induction of Multidrug Resistance Proteins
Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most lethal cancers due to a high chemoresistance and poor vascularization, which results in an ineffective systemic therapy. PDAC is characterized by a high intratumoral pressure, which is not captured by current 2D and 3D in vitro models. Here,...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770899/ https://www.ncbi.nlm.nih.gov/pubmed/31546820 http://dx.doi.org/10.3390/ijms20184647 |
_version_ | 1783455590962429952 |
---|---|
author | Kramer, Bart de Haan, Luuk Vermeer, Marjolein Olivier, Thomas Hankemeier, Thomas Vulto, Paul Joore, Jos Lanz, Henriëtte L. |
author_facet | Kramer, Bart de Haan, Luuk Vermeer, Marjolein Olivier, Thomas Hankemeier, Thomas Vulto, Paul Joore, Jos Lanz, Henriëtte L. |
author_sort | Kramer, Bart |
collection | PubMed |
description | Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most lethal cancers due to a high chemoresistance and poor vascularization, which results in an ineffective systemic therapy. PDAC is characterized by a high intratumoral pressure, which is not captured by current 2D and 3D in vitro models. Here, we demonstrated a 3D microfluidic interstitial flow model to mimic the intratumoral pressure in PDAC. We found that subjecting the S2-028 PDAC cell line to interstitial flow inhibits the proliferation, while maintaining a high viability. We observed increased gemcitabine chemoresistance, with an almost nine-fold higher EC50 as compared to a monolayer culture (31 nM versus 277 nM), and an alleviated expression and function of the multidrug resistance protein (MRP) family. In conclusion, we developed a 3D cell culture modality for studying intratissue pressure and flow that exhibits more predictive capabilities than conventional 2D cell culture and is less time-consuming, and more scalable and accessible than animal models. This increase in microphysiological relevance might support improved efficiency in the drug development pipeline. |
format | Online Article Text |
id | pubmed-6770899 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-67708992019-10-30 Interstitial Flow Recapitulates Gemcitabine Chemoresistance in A 3D Microfluidic Pancreatic Ductal Adenocarcinoma Model by Induction of Multidrug Resistance Proteins Kramer, Bart de Haan, Luuk Vermeer, Marjolein Olivier, Thomas Hankemeier, Thomas Vulto, Paul Joore, Jos Lanz, Henriëtte L. Int J Mol Sci Article Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most lethal cancers due to a high chemoresistance and poor vascularization, which results in an ineffective systemic therapy. PDAC is characterized by a high intratumoral pressure, which is not captured by current 2D and 3D in vitro models. Here, we demonstrated a 3D microfluidic interstitial flow model to mimic the intratumoral pressure in PDAC. We found that subjecting the S2-028 PDAC cell line to interstitial flow inhibits the proliferation, while maintaining a high viability. We observed increased gemcitabine chemoresistance, with an almost nine-fold higher EC50 as compared to a monolayer culture (31 nM versus 277 nM), and an alleviated expression and function of the multidrug resistance protein (MRP) family. In conclusion, we developed a 3D cell culture modality for studying intratissue pressure and flow that exhibits more predictive capabilities than conventional 2D cell culture and is less time-consuming, and more scalable and accessible than animal models. This increase in microphysiological relevance might support improved efficiency in the drug development pipeline. MDPI 2019-09-19 /pmc/articles/PMC6770899/ /pubmed/31546820 http://dx.doi.org/10.3390/ijms20184647 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kramer, Bart de Haan, Luuk Vermeer, Marjolein Olivier, Thomas Hankemeier, Thomas Vulto, Paul Joore, Jos Lanz, Henriëtte L. Interstitial Flow Recapitulates Gemcitabine Chemoresistance in A 3D Microfluidic Pancreatic Ductal Adenocarcinoma Model by Induction of Multidrug Resistance Proteins |
title | Interstitial Flow Recapitulates Gemcitabine Chemoresistance in A 3D Microfluidic Pancreatic Ductal Adenocarcinoma Model by Induction of Multidrug Resistance Proteins |
title_full | Interstitial Flow Recapitulates Gemcitabine Chemoresistance in A 3D Microfluidic Pancreatic Ductal Adenocarcinoma Model by Induction of Multidrug Resistance Proteins |
title_fullStr | Interstitial Flow Recapitulates Gemcitabine Chemoresistance in A 3D Microfluidic Pancreatic Ductal Adenocarcinoma Model by Induction of Multidrug Resistance Proteins |
title_full_unstemmed | Interstitial Flow Recapitulates Gemcitabine Chemoresistance in A 3D Microfluidic Pancreatic Ductal Adenocarcinoma Model by Induction of Multidrug Resistance Proteins |
title_short | Interstitial Flow Recapitulates Gemcitabine Chemoresistance in A 3D Microfluidic Pancreatic Ductal Adenocarcinoma Model by Induction of Multidrug Resistance Proteins |
title_sort | interstitial flow recapitulates gemcitabine chemoresistance in a 3d microfluidic pancreatic ductal adenocarcinoma model by induction of multidrug resistance proteins |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770899/ https://www.ncbi.nlm.nih.gov/pubmed/31546820 http://dx.doi.org/10.3390/ijms20184647 |
work_keys_str_mv | AT kramerbart interstitialflowrecapitulatesgemcitabinechemoresistanceina3dmicrofluidicpancreaticductaladenocarcinomamodelbyinductionofmultidrugresistanceproteins AT dehaanluuk interstitialflowrecapitulatesgemcitabinechemoresistanceina3dmicrofluidicpancreaticductaladenocarcinomamodelbyinductionofmultidrugresistanceproteins AT vermeermarjolein interstitialflowrecapitulatesgemcitabinechemoresistanceina3dmicrofluidicpancreaticductaladenocarcinomamodelbyinductionofmultidrugresistanceproteins AT olivierthomas interstitialflowrecapitulatesgemcitabinechemoresistanceina3dmicrofluidicpancreaticductaladenocarcinomamodelbyinductionofmultidrugresistanceproteins AT hankemeierthomas interstitialflowrecapitulatesgemcitabinechemoresistanceina3dmicrofluidicpancreaticductaladenocarcinomamodelbyinductionofmultidrugresistanceproteins AT vultopaul interstitialflowrecapitulatesgemcitabinechemoresistanceina3dmicrofluidicpancreaticductaladenocarcinomamodelbyinductionofmultidrugresistanceproteins AT joorejos interstitialflowrecapitulatesgemcitabinechemoresistanceina3dmicrofluidicpancreaticductaladenocarcinomamodelbyinductionofmultidrugresistanceproteins AT lanzhenriettel interstitialflowrecapitulatesgemcitabinechemoresistanceina3dmicrofluidicpancreaticductaladenocarcinomamodelbyinductionofmultidrugresistanceproteins |